We are live on ! Find out more
TENX icon

Tenax Therapeutics

50 hedge funds and large institutions have $85.9M invested in Tenax Therapeutics in 2025 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 12 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

576% more capital inflows, than outflows

Capital inflows: $24.4M | Capital outflows: $3.6M

320% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 5

300% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 3

51.03% more ownership

Funds ownership: 103.47% → 154.5% (+51%)

47% more funds holding

Funds holding: 34 → 50 (+16)

Holders
50
Holders Change
+16
Holders Change %
+47.06%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
12
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

TENX Hedge Fund Activity: Q4 2025 in Review

50 of the 8,319 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q4 2025, worth a combined $85.9M — up 139% from $35.9M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new TENX positions and 5 closed out — a net gain of 16 holders — while 12 added to existing stakes and 3 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $3.82M. The largest seller was VR Adviser, exiting entirely with an estimated $3.33M sold.

  • 50 institutional investors held Tenax Therapeutics (TENX) as of Q4 2025, up from 34 in Q3 2025.
  • Funds reported $85.9M of Tenax Therapeutics stock for Q4 2025, up 139% quarter-over-quarter.
  • 21 funds opened new Tenax Therapeutics positions in Q4 2025 and 5 closed out, a net change of +16 holders.
  • The largest Tenax Therapeutics buyer in Q4 2025 was Perceptive Advisors, an estimated $3.82M added.
  • The largest Tenax Therapeutics seller in Q4 2025 was VR Adviser, an estimated $3.33M sold.

Based on aggregated 13F filings for Q4 2025.